Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001773751-22-000059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-02 | 2022-02-28 | HIMS | Carroll Patrick Harrison | Dir | S - Sale+OE | $5.17 | -86.8K | 123.7K | -41% | -$448.9K |
| DM | 2022-03-02 | 2022-02-28 | HIMS | Carroll Patrick Harrison | Dir | M - OptEx | $2.27 | +189.7K | 105.9K | New | +$431.1K |
| DM | 2022-03-02 | 2022-02-28 | HIMS | Carroll Patrick Harrison | Dir | M - OptEx | $0.00 | -189.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-28 | S | D | 86,820 | $5.17 | 123,719 | D | — | — | (F1) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $5.055 - $5.27. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2022-02-28 | M | A | 43,882 | $1.75 | 64,739 | D | — | — | |
| 3 | Common | Class A Common Stock | 2022-02-28 | M | A | 86,820 | $2.43 | 210,539 | D | — | — | |
| 4 | Common | Class A Common Stock | 2022-02-28 | M | A | 17,801 | $2.43 | 123,719 | D | — | — | |
| 5 | Common | Class A Common Stock | 2022-02-28 | M | A | 41,179 | $2.43 | 105,918 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2022-02-28 | M | D | 17,801 | $0.00 | 0 | D | $2.43 · — to 2030-05-12 | 17,801 Class A Common Stock | (F3) 25% of the shares vested on the 12 month anniversary of the vesting commencement date of December 5, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date. |
| 7 | Derivative | Stock Option (right to buy) | 2022-02-28 | M | D | 43,882 | $0.00 | 0 | D | $1.75 · — to 2029-07-08 | 43,882 Class A Common Stock | (F2) 25% of the shares vested on the 12 month anniversary of the vesting commencement date of June 17, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date. |
| 8 | Derivative | Stock Option (right to buy) | 2022-02-28 | M | D | 86,820 | $0.00 | 0 | D | $2.43 · — to 2030-05-12 | 86,820 Class A Common Stock | (F4) 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020. |
| 9 | Derivative | Stock Option (right to buy) | 2022-02-28 | M | D | 41,179 | $0.00 | 0 | D | $2.43 · — to 2030-05-12 | 41,179 Class A Common Stock | (F3) 25% of the shares vested on the 12 month anniversary of the vesting commencement date of December 5, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date. |